Pathology of childhood epilepsiesa

Epilepsy in Children, 2E

Volumn , Issue , 2004, Pages 81-94

  Miyata, Hajime ^a,b   Vinters, Harry V ^a  

^a UCLA MEDICAL CENTER   (United States)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881312935     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (119)

1. Friede RL. (ed.) Developmental Neuropathology, 2nd revised and expanded edition. Berlin: Springer-Verlag, 1989.
2. Chugani HT, Shewmon DA, Shields WD, et al. Surgery for intractable infantile spasms: neuroimaging perspectives. Epilepsia 1993; 34: 764-771.
3. Shields WD, Duchowny MS, Holmes GL. Surgically remediable syndromes of infancy and early childhood. In: Engel J Jr. (ed.) Surgical Treatment of the Epilepsies, 2nd edn. New York: Raven Press, 1993: 35-48.
4. De Rosa MJ, Farrell MA, Burke MM, Secor DL, Vinters HV. An assessment of the proliferative potential of ‘balloon cells’ in focal cortical resections performed for childhood epilepsy. Neuropathology and Applied Neurobiology 1992; 18: 566-574.
5. Duong T, De Rosa MJ, Poukens V, Vinters HV, Fisher RS. Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia. Acta Neuropathologica 1994; 87: 493-503.
6. Vinters HV, Wang R, Wiley CA. Herpesviruses in chronic encephalitis associated with intractable childhood epilepsy. Human Pathology 1993; 24: 871-879.
7. Nuovo GJ, Forde A, MacConnell P, Fahrenwald R. In situ detection of PCR-amplified HIV-1 nucleic acids and tumor necrosis factor cDNA in cervical tissues. American Journal of Pathology 1993; 143: 40-48.
8. Crino PB, Trojanowski JQ, Dichter MA, Eberwine J. Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology. Proceedings of the National Academy of Sciences of the USA 1996; 93: 14152-14157.
9. Kacharmina JE, Crino PB, Eberwine J. Preparation of cDNA from single cells and subcellular regions. Methods in Enzymology 1999; 303: 3-18.
10. Wuarin JP, Kim YI, Cepeda C, et al. Synaptic transmission in human neocortex removed for treatment of intractable epilepsy in children. Annals of Neurology 1990; 28: 503-511.
11. Mathern GW, Cepeda C, Hurst RS, Flores-Hernandez J, Mendoza D, Levine MS. Neurons recorded from pediatric epilepsy surgery patients with cortical dysplasia. Epilepsia 2000; 41 (Suppl 6): S162-167.
12. Vinters HV, Armstrong DL, Babb TL, et al. The neuropathology of human symptomatic epilepsy. In: Engel J Jr. (ed.) Surgical Treatment of the Epilepsies, 2nd edn. New York: Raven Press, 1993: 593-608.
13. Vinters HV, Mah V, Shields WD. Neuropathologic correlates of pediatric epilepsy. Journal of Epilepsy 1990; 3 (Suppl): 227-235.
14. Farrell MA, DeRosa MJ, Curran JG, et al. Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy. Acta Neuropathologica 1992; 83: 246-259.
15. Vinters HV, Fisher RS, Cornford ME, et al. Morphological substrates of infantile spasms: studies based on surgically resected cerebral tissue. Child’s Nervous System 1992; 8: 8-17.
16. Robain O, Vinters HV. Neuropathologic studies in West syndrome. In: Dulac O, Chugani HT, Dalla Bernardina B. (eds) Infantile Spasms and West syndrome. London: W.B. Saunders, 1994: 99-117.
17. Meencke HJ, Janz D. Neuropathological findings in primary generalized epilepsy: a study of eight cases. Epilepsia 1984; 25: 8-21.
18. Lyon G, Gastaut H. Considerations on the significance attributed to unusual cerebral histological findings recently described in eight patients with primary generalized epilepsy. Epilepsia 1985; 26: 365-367.
19. Robitaille Y, Rasmussen T, Dubeau F, Tampieri D, Kemball K. Histopathology of nonneoplastic lesions in frontal lobe epilepsy. Review of 180 cases with recent MRI and PET correlations. Advances in Neurology 1992; 57: 499-513.
20. Wolf HK, Zentner J, Hufnagel A, et al. Surgical pathology of chronic epileptic seizure disorders: experience with 63 specimens from extratemporal corticectomies, lobectomies and functional hemispherectomies. Acta Neuropathologica 1993; 86: 466-472.
21. Armstrong DD. The neuropathology of temporal lobe epilepsy. Journal of Neuropathology and Experimental Neurology 1993; 52: 433-443.
22. Plate KH, Wieser HG, Yasargil MG, Wiestler OD. Neuropathological findings in 224 patients with temporal lobe epilepsy. Acta Neuropathologica 1993; 86: 433-438.
23. Wolf HK, Campos MG, Zentner J, et al. Surgical pathology of temporal lobe epilepsy. Experience with 216 cases. Journal of Neuropathology and Experimental Neurology 1993; 52: 499-506.
24. Levesque MF, Nakasato N, Vinters HV, Babb TL. Surgical treatment of limbic epilepsy associated with extrahippocampal lesions: the problem of dual pathology. Journal of Neurosurgery 1991; 75: 364-370.
25. Adelson PD, Peacock WJ, Chugani HT, et al. Temporal and extended temporal resections for the treatment of intractable seizures in early childhood. Pediatric Neurosurgery 1992; 18: 169-178.
26. Norman MG. Perinatal brain damage. Perspectives in Pediatric Pathology 1978; 4: 41-92.
27. Fenichel GM. Hypoxic-ischemic encephalopathy in the newborn. Archives of Neurology 1983; 40: 261-266.
28. Guzzetta F. Ischemic and hemorrhagic cerebral lesions of the newborn. Current concepts. Child’s Nervous System 1991; 7: 417-424.
29. Rorke LB. Anatomical features of the developing brain implicated in pathogenesis of hypoxic-ischemic injury. Brain Pathology 1992; 2: 211-221.
30. Younkin DP. Hypoxic-ischemic brain injury of the newborn - statement of the problem and overview. Brain Pathology 1992; 2: 209-10.
31. Vinters HV. Vascular diseases. In: Duckett S. (ed.) Pediatric Neuropathology. Baltimore: Williams & Wilkins, 1994: 302-333.
32. Cochrane DD, Poskitt KJ, Norman MG. Surgical implications of cerebral dysgenesis. Canadian Journal of Neurological Science 1991; 18: 181-195.
33. Hirabayashi S, Binnie CD, Janota I, Polkey CE. Surgical treatment of epilepsy due to cortical dysplasia: clinical and EEG findings. Journal of Neurology, Neurosurgery and Psychiatry 1993; 56: 765-770.
34. Taylor DC, Falconer MA, Bruton CJ, Corsellis JA. Focal dysplasia of the cerebral cortex in epilepsy. Journal of Neurology, Neurosurgery and Psychiatry 1971; 34: 369-387.
35. Vinters HV, De Rosa MJ, Farrell MA. Neuropathologic study of resected cerebral tissue from patients with infantile spasms. Epilepsia 1993; 34: 772-779.
36. Mischel PS, Nguyen LP, Vinters HV. Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. Journal of Neuropathology and Experimental Neurology 1995; 54: 137-153.
37. Crino PB, Trojanowski JQ, Eberwine J. Internexin, MAP1B, and nestin in cortical dysplasia as markers of developmental maturity. Acta Neuropathologica 1997; 93: 619-627.
38. Duggal N, Iskander S, Hammond RR. Nestin expression in cortical dysplasia. Journal of Neurosurgery 2001; 95: 459-465.
39. Palmini A, Gambardella A, Andermann F, et al. Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Annals of Neurology 1995; 37: 476-487.
40. Preul MC, Leblanc R, Cendes F, et al. Function and organization in dysgenic cortex. Case report. Journal of Neurosurgery 1997; 87: 113-121.
41. Kothare SV, VanLandingham K, Armon C, Luther JS, Friedman A, Radtke RA. Seizure onset from periventricular nodular heterotopias: depth-electrode study. Neurology 1998; 51: 1723-1727.
42. Mattia D, Olivier A, Avoli M. Seizure-like discharges recorded in human dysplastic neocortex maintained in vitro. Neurology 1995; 45: 1391-1395.
43. Avoli M, Bernasconi A, Mattia D, Olivier A, Hwa GG. Epileptiform discharges in the human dysplastic neocortex: in vitro physiology and pharmacology. Annals of Neurology 1999; 46: 816-826.
44. Spreafico R, Battaglia G, Arcelli P, et al. Cortical dysplasia: an immunocytochemical study of three patients. Neurology 1998; 50: 27-36.
45. White R, Hua Y, Scheithauer B, Lynch DR, Henske EP, Crino PB. Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers. Annals of Neurology 2001; 49: 67-78.
46. Crino PB, Duhaime AC, Baltuch G, White R. Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia. Neurology 2001; 56: 906-913.
47. Kerfoot C, Vinters HV, Mathern GW. Cerebral cortical dysplasia: giant neurons show potential for increased excitation and axonal plasticity. Developmental Neuroscience 1999; 21: 260-270.
48. Mikuni N, Babb TL, Ying Z, et al. NMDA-receptors 1 and 2A/B coassembly increased in human epileptic focal cortical dysplasia. Epilepsia 1999; 40: 1683-1687.
49. Crino PB, Jin H, Shumate MD, Robinson MB, Coulter DA, Brooks-Kayal AR. Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy. Epilepsia 2002; 43: 211-218.
50. Kuzniecky R, Garcia JH, Faught E, Morawetz RB. Cortical dysplasia in temporal lobe epilepsy: magnetic resonance imaging correlations. Annals of Neurology 1991; 29: 293-298.
51. Simone IL, Federico F, Tortorella C, et al. Metabolic changes in neuronal migration disorders: evaluation by combined MRI and proton MR spectroscopy. Epilepsia 1999; 40: 872-879.
52. Marusic P, Najm IM, Ying Z, et al. Focal cortical dysplasia in eloquent cortex: functional characteristics and correlation with MRI and histopathologic changes. Epilepsia 2002; 43: 27-32.
53. Mathern GW, Giza CC, Yudovin S, et al. Postoperative seizure control and antiepileptic drug use in pediatric epilepsy surgery patients: the UCLA experience, 1986-1997. Epilepsia 1999; 40: 1740-1749.
54. Rakic P. Molecular and cellular mechanisms of neuronal migration: relevance to cortical epilepsies. Advances in Neurology 2000; 84: 1-14.
55. van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997; 277: 805-808.
56. The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993; 75: 1305-1315.
57. Fox JW, Lamperti ED, Eksioglu YZ, et al. Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron 1998; 21: 1315-1325.
58. Crino PB, Miyata H, Vinters HV. Neurodevelopmental disorders as a cause of seizures: Neuropathologic, genetic and mechanistic considerations. Brain Pathology 2002; 12: 212-233.
59. Palmini A, Andermann F, de Grissac H, et al. Stages and patterns of centrifugal arrest of diffuse neuronal migration disorders. Developmental Medicine and Child Neurology 1993; 35: 331-339.
60. King M, Stephenson JB, Ziervogel M, Doyle D, Galbraith S. Hemimegalencephaly - a case for hemispherectomy? Neuropediatrics 1985; 16: 46-55.
61. De Rosa MJ, Secor DL, Barsom M, Fisher RS, Vinters HV. Neuropathologic findings in surgically treated hemimegalencephaly: immunohistochemical, morphometric, and ultrastructural study. Acta Neuropathologica 1992; 84: 250-260.
62. Robain O, Floquet C, Heldt N, Rozenberg F. Hemimegalencephaly: a clinicopathological study of four cases. Neuropathology and Applied Neurobiology 1988; 14: 125-135.
63. Critchley M, Earl CJC. Tuberous sclerosis and allied conditions. Brain 1932; 55: 311-346.
64. Bender BL, Yunis EJ. Central nervous system pathology of tuberous sclerosis in children. Ultrastructal Pathology 1980; 1: 287-299.
65. Dumas JL, Poirier J, Escourolle R. Ultrastructural study of cerebral lesions in tuberous sclerosis. Acta Neuropathologica 1973; 25: 259-270.
66. Thibault JH, Manuelidis EE. Tuberous sclerosis in a premature infant. Report of a case and review of the literature. Neurology 1970; 20: 139-146.
67. Probst A, Ohnacker H. Sclérose tubereuse de Bourneville chez un prématuré. Ultrastructure des cellules atypiques: presence de microvillosités. Acta Neuropathologica 1977; 40: 157-161.
68. Park SH, Pepkowitz SH, Kerfoot C, et al. Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study. Acta Neuropathologica 1997; 94: 180-186.
69. Catania MG, Mischel PS, Vinters HV. Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B. Journal of Neuropathology and Experimental Neurology 2001; 60: 711-723.
70. Hengstschläger M, Rodman DM, Miloloza A, Hengstschläger-Ottnad E, Rosner M, Kubista M. Tuberous sclerosis gene products in proliferation control. Mutation Research 2001; 488: 233-239.
71. Lamb RF, Roy C, Diefenbach TJ, et al. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nature Cell Biology 2000; 2: 281-287.
72. Wienecke R, König A, DeClue JE. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. Journal of Biological Chemistry 1995; 270: 16409-16414.
73. Xiao GH, Shoarinejad F, Jin F, Golemis EA, Yeung RS. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase-activating protein (GAP) in modulating endocytosis. Journal of Biological Chemistry 1997; 272: 6097-6100.
74. Wienecke R, Maize JC Jr, Shoarinejad F, et al. Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. Oncogene 1996; 13: 913-923.
75. Soucek T, Holzl G, Bernaschek G, Hengstschläger M. A role of the tuberous sclerosis gene-2 product during neuronal differentiation. Oncogene 1998; 16: 2197-2204.
76. Potter CJ, Huang H, Xu T. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell 2001; 105: 357-368.
77. Kwiatkowski DJ, Zhang H, Bandura JL, et al. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Human Molecular Genetics 2002; 11: 525-534.
78. Luo L. Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 2000; 1: 173-180.
79. Louvet-Vallée S. ERM proteins: from cellular architecture to cell signaling. Biology of the Cell 2000; 92: 305-316.
80. Johnson MW, Miyata H, Vinters HV. Ezrin and moesin expression within the developing human cerebrum and tuberous sclerosis-associated cortical tubers. Acta Neuropathologica 2002; 104: 188-196.
81. McKay DJG, Esch F, Furthmayr H, Hall A. Rho- and rac-dependent assembly of focal adhesion complexes and actin filaments in permeabilized fibroblasts: an essential role for ezrin/radixin/moesin proteins. Journal of Cell Biology 1997; 138: 927-938.
82. Takahashi K, Sasaki T, Mammoto A, et al. Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein. Journal of Biological Chemistry 1997; 272: 23371-23375.
83. Olenik C, Aktories K, Meyer DK. Differential expression of the small GTP-binding proteins RhoA, RhoB, Cdc42u and Cdc42b in developing rat neocortex. Brain Research. Molecular Brain Research 1999; 18: 9-17.
84. Lambert de Rouvroit C, Goffinet AM. Neuronal migration. Mechanisms of Development 2001; 105: 47-56.
85. Johnson MW, Emelin JK, Park SH, Vinters HV. Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis. Brain Pathology 1999; 9: 45-54.
86. Miloloza A, Kubista M, Rosner M, Hengstschläger M. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation. Journal of Neuropathology and Experimental Neurology 2002; 61: 154-163.
87. Vinters HV. Histopathology of brain tissue from patients with infantile spasms. International Review of Neurobiology 2002; 49: 63-76.
88. Peacock WJ, Wehby-Grant MC, Shields WD, et al. Hemispherectomy for intractable seizures in children: A report of 58 cases. Child’s Nervous System 1996; 12: 376-384.
89. Prayson RA. Clinicopathological findings in patients who have undergone epilepsy surgery in the first year of life. Pathology International 2000; 50: 620-625.
90. Yamanouchi H, Jay V, Otsubo H, Kaga M, Becker LE, Takashima S. Early forms of microtubule-associated protein are strongly expressed in cortical dysplasia. Acta Neuropathologica 1998; 95: 466-470.
91. Arai Y, Edwards V, Becker LE. A comparison of cell phenotypes in hemimegalencephaly and tuberous sclerosis. Acta Neuropathologica 1999; 98: 407-413.
92. Nishio S, Morioka T, Hamada Y, Hisada K, Fukui M. Immunohistochemical expression of trk receptor proteins in focal cortical dysplasia with intractable epilepsy. Neuropathology and Applied Neurobiology 1999; 25: 188-195.
93. Vinters HV, Park SH, Johnson MW, Mischel PS, Catania M, Kerfoot C. Cortical dysplasia, genetic abnormalities and neurocutaneous syndromes. Developmental Neuroscience 1999; 21: 248-259.
94. Kyin R, Hua Y, Baybis M, et al. Differential cellular expression of neurotrophins in cortical tubers of the tuberous sclerosis complex. American Journal of Pathology 2001; 159: 1541-1554.
95. Rasmussen T, Olszewski J, Lloyd-Smith D. Focal seizures due to chronic localized encephalitis. Neurology 1958; 8: 435-445.
96. Aguilar MJ, Rasmussen T. Role of encephalitis in pathogenesis of epilepsy. Archives of Neurology 1960; 2: 663-676.
97. Rasmussen T. Further observations on the syndrome of chronic encephalitis and epilepsy. Applied Neurophysiology 1978; 41: 1-12.
98. Bien CG, Bauer J, Deckwerth TL, et al. Destruction of neurons by cytotoxic T cells: A new pathogenic mechanism in Rasmussen’s encephalitis. Annals of Neurology 2002; 51: 311-318.
99. Villani F, Spreafico R, Farina L, et al. Positive response to immunomodulatory therapy in an adult patient with Rasmussen’s encephalitis. Neurology 200; 56: 248-250.
100. Zupanc ML, Handler EG, Levine RL, et al. Rasmussen encephalitis: epilepsia partialis continua secondary to chronic encephalitis. Pediatric Neurology 1990; 6: 397-401.
101. Honavar M, Janota I, Polkey CE. Rasmussen’s encephalitis in surgery for epilepsy. Developmental Medicine and Child Neurology 1992; 34: 3-14.
102. Vining EP, Freeman JM, Pillas DJ, et al. Why would you remove half a brain? The outcome of 58 children after hemispherectomy - the Johns Hopkins experience: 1968 to 1996. Pediatrics 1997; 100: 163-171.
103. Robitaille Y. Neuropathologic aspects of chronic encephalitis. In: Andermann F. (ed.) Chronic Encephalitis and Epilepsy, Rasmussen’s Syndrome. Oxford: Butterworth-Heinemann, 1991: 79-110.
104. Gordon N. Chronic progressive epilepsia partialis continua of childhood: Rasmussen syndrome. Developmental Medicine and Child Neurology 1992; 34: 182-185.
105. Walter GF, Renella RR, Hori A, Wirnsberger G. Nachweis von Epstein-Barr-Viren bei Rasmussen’s Enzephalitis. Nervenarzt 1989; 60: 168-170.
106. Power C, Poland SD, Blume WT, Girvin JP, Rice GP. Cytomegalovirus and Rasmussen’s encephalitis. Lancet 1990; 336: 1282-1284.
107. Farrell MA, Cheng L, Cornford ME, Grody WW, Vinters HV. Cytomegalovirus and Rasmussen’s encephalitis. Lancet 1991; 337: 1551-1552.
108. Rogers SW, Andrews PI, Gahring LC, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen’s encephalitis. Science 1994; 265: 648-651.
109. He XP, Patel M, Whitney KD, Janumpalli S, Tenner A, McNamara JO. Glutamate receptor GluR3 antibodies and death of cortical cells. Neuron 1998; 20: 153-163.
110. Whitney KD, Andrews PI, McNamara JO. Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen’s encephalitis. Neurology 1999; 53: 699-708.
111. Frassoni C, Spreafico R, Franceschetti S, et al. Labeling of rat neurons by anti-GluR3 IgG from patients with Rasmussen encephalitis. Neurology 2001; 57: 324-327.
112. Whitney KD, McNamara JO. GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins. Journal of Neuroscience 2000; 20: 7307-7316.
113. Wohlwill FJ, Yakovlev PI. Histopathology of meningo-facial angiomatosis (Sturge-Weber’s disease). Journal of Neuropathology and Experimental Neurology 1957; 16: 341-364.
114. Venes JL, Linder S. Sturge-Weber-Dimitri syndrome. Encephalotrigeminal angiomatosis. In: Edwards MSB, Hoffman HJ. (eds) Cerebral Vascular Disease in Children and Adolescents. Baltimore: Williams & Wilkins, 1989: 337-341.
115. Oakes WJ. The natural history of patients with the Sturge-Weber syndrome. Pediatric Neurosurgery 1992; 18: 287-290.
116. Bentz MS, Towfighi J, Greenwood S, Zaino R. Sturge-Weber syndrome. A case with thyroid and choroid plexus hemangiomas and leptomeningeal melanosis. Archives of Pathology and Laboratory Medicine 1982; 106: 75-78.
117. Guseo A. Ultrastructure of calcification in Sturge-Weber Disease. Virchows Archiv A Pathological Anatomy and Histopathology 1975; 366: 353-356.
118. Norman MG, Schoene WC. The ultrastructure of Sturge-Weber disease. Acta Neuropathologica 1977; 37: 199-205.
119. Najm I, Ying Z, Janigro D. Mechanisms of epileptogenesis. Neurologic Clinics 2001; 19: 237-250.